IBRX
Income statement / Annual
Last year (2023), ImmunityBio, Inc.'s total revenue was $622,000.00,
an increase of 159.17% from the previous year.
In 2023, ImmunityBio, Inc.'s net income was -$583.20 M.
See ImmunityBio, Inc.�s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$622,000.00
|
$240,000.00
|
$934,000.00
|
$605,000.00
|
$2.20 M
|
$47,000.00
|
$45,000.00
|
$44,000.00
|
$236,000.00
|
$641,000.00
|
| Cost of Revenue |
$0.00 |
$24.19 M |
$0.00 |
$9.15 M |
$9.01 M |
-$3.11 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$622,000.00 |
-$23.95 M |
$934,000.00 |
-$8.54 M |
-$6.81 M |
$3.16 M |
$45,000.00 |
$44,000.00 |
$236,000.00 |
$641,000.00 |
| Gross Profit Ratio |
1 |
-99.8 |
1 |
-14.12 |
-3.09 |
67.17 |
1 |
1 |
1 |
1 |
| Research and Development
Expenses |
$232.37 M
|
$248.15 M
|
$195.96 M
|
$139.51 M
|
$112.00 M
|
$53.42 M
|
$39.78 M
|
$26.55 M
|
$11.43 M
|
$1.60 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$28.39 M
|
$57.12 M
|
$95.39 M
|
$227.68 M
|
$4.33 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$7.07 M
|
-$3.30 M
|
-$1.00 M
|
-$1.47 M
|
$0.00
|
| Selling, General &
Administrative Expenses |
$129.62 M
|
$102.71 M
|
$135.26 M
|
$71.32 M
|
$46.46 M
|
$35.46 M
|
$53.82 M
|
$94.39 M
|
$226.21 M
|
$4.33 M
|
| Other Expenses |
$886,000.00 |
-$736,000.00 |
$193,000.00 |
$1.49 M |
-$534,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$362.87 M |
$350.86 M |
$331.21 M |
$210.83 M |
$158.45 M |
$88.88 M |
$93.60 M |
$120.94 M |
$237.64 M |
$5.92 M |
| Cost And Expenses |
$362.87 M |
$350.86 M |
$331.21 M |
$210.83 M |
$158.45 M |
$98.44 M |
$99.17 M |
$124.54 M |
$239.11 M |
$6.24 M |
| Interest Income |
$863,000.00 |
$2.71 M |
$836,000.00 |
$1.73 M |
$2.76 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$129.20 M |
$63.52 M |
$14.85 M |
$9.07 M |
$5.92 M |
$433,000.00 |
$618,000.00 |
$66,000.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$18.51 M
|
$24.19 M
|
$19.12 M
|
$9.15 M
|
$9.01 M
|
$9.56 M
|
$5.57 M
|
$3.61 M
|
$1.47 M
|
$128,000.00
|
| EBITDA |
-$436.18 M
|
-$335.51 M
|
-$315.38 M
|
-$187.93 M
|
-$142.27 M
|
-$86.74 M
|
-$90.73 M
|
-$117.71 M
|
-$235.71 M
|
-$5.68 M
|
| EBITDA Ratio |
-701.26 |
-1433.24 |
-338.66 |
-322.53 |
-63.57 |
-1890.09 |
-2078.98 |
-2747.57 |
-1005.95 |
-9.49 |
| Operating Income Ratio
|
-582.4
|
-1463.74
|
-353.62
|
-365.09
|
-70.96
|
-2093.38
|
-2202.67
|
-2829.55
|
-1012.19
|
-9.69
|
| Total Other
Income/Expenses Net |
-$221.64 M
|
-$65.99 M
|
-$19.56 M
|
-$25.36 M
|
-$3.95 M
|
$1.66 M
|
$2.20 M
|
$3.12 M
|
$1.70 M
|
-$609,000.00
|
| Income Before Tax |
-$583.89 M |
-$417.29 M |
-$349.84 M |
-$226.03 M |
-$160.26 M |
-$96.73 M |
-$96.92 M |
-$121.38 M |
-$237.18 M |
-$6.21 M |
| Income Before Tax Ratio
|
-938.73
|
-1738.69
|
-374.56
|
-373.61
|
-72.78
|
-2058.06
|
-2153.69
|
-2758.66
|
-1004.99
|
-9.69
|
| Income Tax Expense |
-$40,000.00 |
$34,000.00 |
$9,000.00 |
-$1.85 M |
-$105,000.00 |
-$503,000.00 |
-$493,000.00 |
-$572,000.00 |
-$301,000.00 |
$1,000.00 |
| Net Income |
-$583.20 M |
-$417.32 M |
-$349.85 M |
-$224.19 M |
-$160.16 M |
-$96.23 M |
-$96.42 M |
-$120.81 M |
-$236.88 M |
-$6.21 M |
| Net Income Ratio |
-937.61 |
-1738.83 |
-374.57 |
-370.56 |
-72.73 |
-2047.36 |
-2142.73 |
-2745.66 |
-1003.71 |
-9.69 |
| EPS |
-1.15 |
-1.04 |
-0.9 |
-0.59 |
-0.42 |
-1.22 |
-1.2 |
-1.47 |
-3.31 |
-0.0197 |
| EPS Diluted |
-1.15 |
-1.04 |
-0.9 |
-0.59 |
-0.42 |
-1.22 |
-1.2 |
-1.47 |
-3.31 |
-0.0197 |
| Weighted Average Shares
Out |
$508.64 M
|
$399.90 M
|
$389.23 M
|
$383.18 M
|
$383.18 M
|
$79.13 M
|
$80.58 M
|
$81.98 M
|
$71.52 M
|
$315.73 M
|
| Weighted Average Shares
Out Diluted |
$508.64 M
|
$399.90 M
|
$389.23 M
|
$383.18 M
|
$383.18 M
|
$79.13 M
|
$80.58 M
|
$81.98 M
|
$71.52 M
|
$315.73 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
